Renamed to Enovis Corporation in June 2022
CFX - Colfax Corporation
NYSE
->
Industrials
->
Specialty Industrial Machinery
Wilmington,
United States
Type: Equity
CFX price evolution
CFX
| (in millions $) | 31 Dec 2021 | 30 Oct 2021 | 30 Jun 2021 | 31 Mar 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $719.37 | $177.48 | $62.31 | $763.65 |
| Short term investments | ||||
| Net receivables | $638.7 | $603.21 | $599.88 | $553.78 |
| Inventory | $776.29 | $780.98 | $663.54 | $606.21 |
| Total current assets | $2303.28 | $1725.69 | $1478.97 | $2077.97 |
| Long term investments | ||||
| Property, plant & equipment | $705.82 | $510.83 | $642.9 | $649.86 |
| Goodwill & intangible assets | $5142.76 | $5224.31 | $5077.45 | $4984.49 |
| Total noncurrent assets | $6212.07 | $6246.63 | $6080.52 | $5988.65 |
| Total investments | ||||
| Total assets | $8515.34 | $7972.31 | $7559.5 | $8066.61 |
| Current liabilities | ||||
| Accounts payable | $504.17 | $472.5 | $453.72 | $406.74 |
| Deferred revenue | ||||
| Short long term debt | $8.31 | $14.34 | $20.48 | $727.37 |
| Total current liabilities | $1023.58 | $975.47 | $899.42 | $1558.41 |
| Long term debt | $2224.01 | $1611.69 | $1708.06 | $1619.33 |
| Total noncurrent liabilities | $2830.33 | $2366.32 | $2308.12 | $2217.13 |
| Total debt | $2232.32 | $1753.29 | $1728.54 | $2346.7 |
| Total liabilities | $3853.91 | $3341.79 | $3207.54 | $3775.55 |
| Shareholders' equity | ||||
| Retained earnings | $589.02 | $590.93 | $565.08 | $536.44 |
| Other shareholder equity | -$516.01 | -$488.66 | -$482.62 | -$491.73 |
| Total shareholder equity | $4617.38 | $4586.54 | $4307.85 | $4246.59 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $719.37 | $97.07 | $109.63 | $245.02 |
| Short term investments | ||||
| Net receivables | $638.7 | $517.01 | $561.87 | $989.42 |
| Inventory | $776.29 | $564.82 | $571.56 | $496.54 |
| Total current assets | $2303.28 | $1361.83 | $1404.24 | $1958.44 |
| Long term investments | ||||
| Property, plant & equipment | $705.82 | $660.9 | $664.56 | $503.34 |
| Goodwill & intangible assets | $5142.76 | $4977.99 | $4921.54 | $3589.53 |
| Total noncurrent assets | $6212.07 | $5989.72 | $5982.59 | $4645.43 |
| Total investments | ||||
| Total assets | $8515.34 | $7351.55 | $7386.83 | $6603.87 |
| Current liabilities | ||||
| Accounts payable | $504.17 | $330.25 | $359.78 | $640.67 |
| Deferred revenue | $147.31 | |||
| Short long term debt | $8.31 | $27.07 | $27.64 | $6.33 |
| Total current liabilities | $1023.58 | $811.66 | $857.31 | $1199.35 |
| Long term debt | $2224.01 | $2343.4 | $2420.58 | $1192.41 |
| Total noncurrent liabilities | $2830.33 | $2952.02 | $3039.89 | $1927.58 |
| Total debt | $2232.32 | $2370.47 | $2448.22 | $1198.74 |
| Total liabilities | $3853.91 | $3763.68 | $3897.2 | $3126.93 |
| Shareholders' equity | ||||
| Retained earnings | $589.02 | $517.37 | $479.56 | $991.84 |
| Other shareholder equity | -$516.01 | -$452.11 | -$483.85 | -$780.18 |
| Total shareholder equity | $4617.38 | $3543.39 | $3441.43 | $3269.76 |
| (in millions $) | 31 Dec 2021 | 30 Oct 2021 | 30 Jun 2021 | 31 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1023.27 | $965.89 | $985.93 | $879.21 |
| Cost of revenue | $604.55 | $566.94 | $508.13 | |
| Gross Profit | $418.73 | $404.87 | $418.98 | $371.08 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $351.67 | $337.56 | $305.72 | |
| Total operating expenses | $352.11 | $340.9 | $343.04 | $309.77 |
| Operating income | $66.61 | $63.99 | $75.94 | $61.31 |
| Income from continuing operations | ||||
| EBIT | $41.95 | $54.6 | $52.65 | |
| Income tax expense | $28.27 | $22.35 | $8.15 | $7.92 |
| Interest expense | $15.59 | $13.54 | $17.8 | $25.66 |
| Net income | ||||
| Net income | -$1.91 | $25.85 | $28.64 | $19.07 |
| Income (for common shares) | -$1.91 | $28.64 | $19.07 | |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3854.3 | $3070.77 | $3327.46 | $3666.81 |
| Cost of revenue | $2240.64 | $1782.66 | $1926.4 | $2533.97 |
| Gross Profit | $1613.66 | $1288.11 | $1401.06 | $1132.84 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1329.38 | $1087.4 | $1132.15 | $818.21 |
| Total operating expenses | $1345.81 | $1125.81 | $1231.06 | $895.9 |
| Operating income | $267.85 | $162.29 | $170 | $236.94 |
| Income from continuing operations | ||||
| EBIT | $210.94 | $140.83 | -$376.51 | $184.23 |
| Income tax expense | $66.69 | -$6.05 | $31.63 | -$0.02 |
| Interest expense | $72.59 | $104.26 | $119.5 | $44.05 |
| Net income | ||||
| Net income | $71.66 | $42.63 | -$527.65 | $140.2 |
| Income (for common shares) | $71.66 | $42.63 | -$527.65 | $140.2 |
| (in millions $) | 31 Dec 2021 | 30 Oct 2021 | 30 Jun 2021 | 31 Mar 2021 |
|---|---|---|---|---|
| Net income | -$1.91 | $76.8 | $28.64 | $19.07 |
| Operating activities | ||||
| Depreciation | $65.28 | $65.94 | $62.78 | |
| Business acquisitions & disposals | -$0.31 | -$127.17 | -$103.47 | |
| Stock-based compensation | $9.12 | $9.46 | $7.81 | |
| Total cash flows from operations | $96.22 | $259.88 | $78.37 | $84.38 |
| Investing activities | ||||
| Capital expenditures | -$26.52 | -$16.91 | -$24.54 | |
| Investments | ||||
| Total cash flows from investing | -$26.83 | -$293.65 | -$144.09 | -$128.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7 | $13.37 | $716.63 | |
| Net borrowings | $468.23 | -$645.84 | -$6.28 | |
| Total cash flows from financing | $473.07 | $111.84 | -$635.97 | $707.65 |
| Effect of exchange rate | -$0.57 | -$1.66 | $0.34 | -$1.44 |
| Change in cash and equivalents | $541.89 | $76.41 | -$701.34 | $662.58 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $71.66 | $42.63 | -$527.65 | $140.2 |
| Operating activities | ||||
| Depreciation | $262.92 | $246.23 | $236.03 | $141.88 |
| Business acquisitions & disposals | -$223.27 | -$69.85 | -$1515.14 | -$272.51 |
| Stock-based compensation | $35.35 | $28.91 | $21.96 | $25.1 |
| Total cash flows from operations | $356.1 | $301.94 | $130.95 | $226.37 |
| Investing activities | ||||
| Capital expenditures | -$97.2 | -$105.23 | -$117.62 | -$34.82 |
| Investments | $139.48 | |||
| Total cash flows from investing | -$320.48 | -$175.08 | -$1632.76 | -$167.85 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $745.18 | $3.5 | $389.69 | -$195.3 |
| Net borrowings | -$150.41 | -$122.88 | $1085.4 | $158.24 |
| Total cash flows from financing | $584.91 | -$131.65 | $1369.49 | -$47.15 |
| Effect of exchange rate | -$2.23 | -$3.77 | -$3.07 | -$28.36 |
| Change in cash and equivalents | $618.3 | -$8.56 | -$135.39 | -$17 |
News
|
Why Is Colfax (CFX) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance
25 Mar 2022
|
|
Is Colfax Corporation's (NYSE:CFX) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance
16 Mar 2022
|
|
Expert Ratings For Colfax
Benzinga
2 Mar 2022
|
|
What 4 Analyst Ratings Have To Say About Colfax
Benzinga
23 Feb 2022
|
|
Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y
Zacks via Yahoo Finance
23 Feb 2022
|
|
Colfax (CFX) Beats Q4 Earnings and Revenue Estimates
Zacks via Yahoo Finance
22 Feb 2022
|
|
Recap: Colfax Q4 Earnings
Benzinga
22 Feb 2022
|
|
Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist
MSN News
20 Feb 2022
|
|
Altra Industrial (AIMC) Q4 Earnings Miss, '22 View Solid
Zacks via Yahoo Finance
17 Feb 2022
|
|
MRC Global (MRC) Q4 Earnings Top Estimates, Sales View Solid
Entrpreneur
16 Feb 2022
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 156.25M |
| Revenue | $3.85B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $71.66M |
| Revenue Q/Q | 23.57% |
| Revenue Y/Y | 25.52% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 32.85 |
| Cash/Share | 4.60 |
| EPS | $0.46 |
|---|---|
| ROA | 0.89% |
| ROE | 1.61% |
| Debt/Equity | 0.83 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.25 |
| Quick ratio | 1.49 |